Loading…
Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers
99DOTS is a cell phone-based strategy for monitoring tuberculosis (TB) medication adherence that has been rolled out to more than 150,000 patients in India's public health sector. A considerable proportion of patients stop using 99DOTS during therapy. This study aims to understand reasons for v...
Saved in:
Published in: | JMIR mHealth and uHealth 2020-07, Vol.8 (7), p.e16634-e16634 |
---|---|
Main Authors: | , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c429t-9e7d513ca8531cfe79df31d113d57e138829a4ca593c119ee4cba18a34f33c0e3 |
---|---|
cites | cdi_FETCH-LOGICAL-c429t-9e7d513ca8531cfe79df31d113d57e138829a4ca593c119ee4cba18a34f33c0e3 |
container_end_page | e16634 |
container_issue | 7 |
container_start_page | e16634 |
container_title | JMIR mHealth and uHealth |
container_volume | 8 |
creator | Thomas, Beena E Kumar, J Vignesh Onongaya, Chidiebere Bhatt, Spurthi N Galivanche, Amith Periyasamy, Murugesan Chiranjeevi, M Khandewale, Amit Subhash Ramachandran, Geetha Shah, Daksha Haberer, Jessica E Mayer, Kenneth H Subbaraman, Ramnath |
description | 99DOTS is a cell phone-based strategy for monitoring tuberculosis (TB) medication adherence that has been rolled out to more than 150,000 patients in India's public health sector. A considerable proportion of patients stop using 99DOTS during therapy.
This study aims to understand reasons for variability in the acceptance and use of 99DOTS by TB patients and health care providers (HCPs).
We conducted qualitative interviews with individuals taking TB therapy in the government program in Chennai and Vellore (HIV-coinfected patients) and Mumbai (HIV-uninfected patients) across intensive and continuation treatment phases. We conducted interviews with HCPs who provide TB care, all of whom were involved in implementing 99DOTS. Interviews were transcribed, coded using a deductive approach, and analyzed with Dedoose 8.0.35 software (SocioCultural Research Consultants, LLC). The findings of the study were interpreted using the unified theory of acceptance and use of technology, which highlights 4 constructs associated with technology acceptance: performance expectancy, effort expectancy, social influences, and facilitating conditions.
We conducted 62 interviews with patients with TB, of whom 30 (48%) were HIV coinfected, and 31 interviews with HCPs. Acceptance of 99DOTS by patients was variable. Greater patient acceptance was related to perceptions of improved patient-HCP relationships from increased phone communication, TB pill-taking habit formation due to SMS text messaging reminders, and reduced need to visit health facilities (performance expectancy); improved family involvement in TB care (social influences); and from 99DOTS leading HCPs to engage positively in patients' care through increased outreach (facilitating conditions). Lower patient acceptance was related to perceptions of reduced face-to-face contact with HCPs (performance expectancy); problems with cell phone access, literacy, cellular signal, or technology fatigue (effort expectancy); high TB- and HIV-related stigma within the family (social influences); and poor counseling in 99DOTS by HCPs or perceptions that HCPs were not acting upon adherence data (facilitating conditions). Acceptance of 99DOTS by HCPs was generally high and related to perceptions that the 99DOTS adherence dashboard and patient-related SMS text messaging alerts improve quality of care, the efficiency of care, and the patient-HCP relationship (performance expectancy); that the dashboard is easy to use (effort expectancy); and |
doi_str_mv | 10.2196/16634 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4a9b64c747c94f48b6a18ddda8ece424</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_4a9b64c747c94f48b6a18ddda8ece424</doaj_id><sourcerecordid>2429785027</sourcerecordid><originalsourceid>FETCH-LOGICAL-c429t-9e7d513ca8531cfe79df31d113d57e138829a4ca593c119ee4cba18a34f33c0e3</originalsourceid><addsrcrecordid>eNpVkt1uEzEQhVcIRKuQV0C-QeKCwPpns2sukEJaaKVWDWq4tmbt2cTVxk5tb0TejkfDTUrVXtnjOfqOR3OKYkzLz4zK6Rc6nXLxqjhlTNJJxRh7_ex-UoxjvCvLklJWMVm9LU44q3lulafF3_M_2x6ss25FzmzXYUCnMRLrSFojmWmN2wSt7W3aE98RKc9ulrefCJA59j1ZrL3DyXeIaMhtCpBwtSedD-TaO5t8eMDOzPpIJcmT5dBi0EPvo43kGo3VkKx38Sv5NUA2ydUOM2owB7tFrtGlSMAZcoHQpzWZQ0CyCH5nDYb4rnjTQR9x_HiOit8_zpfzi8nVzc_L-exqogWTaSKxNhXlGpqKU91hLU3HqaGUm6pGypuGSRAaKsk1pRJR6BZoA1x0nOsS-ai4PHKNhzu1DXYDYa88WHV48GGlICSre1QCZDsVuha1lqITTTvNJGMMNKhRMJFZ346s7dBu0Og8YYD-BfRlx9m1WvmdqgVrZFlmwMdHQPD3A8akNjbqvBBw6IeoWJ65bqoyr3lUfDhKdfAxBuyebGipHsKjDuHJuvfP__Sk-h8V_g8NIsG4</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2429785027</pqid></control><display><type>article</type><title>Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers</title><source>PubMed (Medline)</source><source>Publicly Available Content Database</source><creator>Thomas, Beena E ; Kumar, J Vignesh ; Onongaya, Chidiebere ; Bhatt, Spurthi N ; Galivanche, Amith ; Periyasamy, Murugesan ; Chiranjeevi, M ; Khandewale, Amit Subhash ; Ramachandran, Geetha ; Shah, Daksha ; Haberer, Jessica E ; Mayer, Kenneth H ; Subbaraman, Ramnath</creator><creatorcontrib>Thomas, Beena E ; Kumar, J Vignesh ; Onongaya, Chidiebere ; Bhatt, Spurthi N ; Galivanche, Amith ; Periyasamy, Murugesan ; Chiranjeevi, M ; Khandewale, Amit Subhash ; Ramachandran, Geetha ; Shah, Daksha ; Haberer, Jessica E ; Mayer, Kenneth H ; Subbaraman, Ramnath</creatorcontrib><description>99DOTS is a cell phone-based strategy for monitoring tuberculosis (TB) medication adherence that has been rolled out to more than 150,000 patients in India's public health sector. A considerable proportion of patients stop using 99DOTS during therapy.
This study aims to understand reasons for variability in the acceptance and use of 99DOTS by TB patients and health care providers (HCPs).
We conducted qualitative interviews with individuals taking TB therapy in the government program in Chennai and Vellore (HIV-coinfected patients) and Mumbai (HIV-uninfected patients) across intensive and continuation treatment phases. We conducted interviews with HCPs who provide TB care, all of whom were involved in implementing 99DOTS. Interviews were transcribed, coded using a deductive approach, and analyzed with Dedoose 8.0.35 software (SocioCultural Research Consultants, LLC). The findings of the study were interpreted using the unified theory of acceptance and use of technology, which highlights 4 constructs associated with technology acceptance: performance expectancy, effort expectancy, social influences, and facilitating conditions.
We conducted 62 interviews with patients with TB, of whom 30 (48%) were HIV coinfected, and 31 interviews with HCPs. Acceptance of 99DOTS by patients was variable. Greater patient acceptance was related to perceptions of improved patient-HCP relationships from increased phone communication, TB pill-taking habit formation due to SMS text messaging reminders, and reduced need to visit health facilities (performance expectancy); improved family involvement in TB care (social influences); and from 99DOTS leading HCPs to engage positively in patients' care through increased outreach (facilitating conditions). Lower patient acceptance was related to perceptions of reduced face-to-face contact with HCPs (performance expectancy); problems with cell phone access, literacy, cellular signal, or technology fatigue (effort expectancy); high TB- and HIV-related stigma within the family (social influences); and poor counseling in 99DOTS by HCPs or perceptions that HCPs were not acting upon adherence data (facilitating conditions). Acceptance of 99DOTS by HCPs was generally high and related to perceptions that the 99DOTS adherence dashboard and patient-related SMS text messaging alerts improve quality of care, the efficiency of care, and the patient-HCP relationship (performance expectancy); that the dashboard is easy to use (effort expectancy); and that 99DOTS leads to better coordination among HCPs (social influences). However, HCPs described suboptimal facilitating conditions, including inadequate training of HCPs in 99DOTS, unequal changes in workload, and shortages of 99DOTS medication envelopes.
In India's government TB program, 99DOTS had high acceptance by HCPs but variable acceptance by patients. Although some factors contributing to suboptimal patient acceptance are modifiable, other factors such as TB- and HIV-related stigma and poor cell phone accessibility, cellular signal, and literacy are more difficult to address. Screening for these barriers may facilitate targeting of 99DOTS to patients more likely to use this technology.</description><identifier>ISSN: 2291-5222</identifier><identifier>EISSN: 2291-5222</identifier><identifier>DOI: 10.2196/16634</identifier><identifier>PMID: 32735220</identifier><language>eng</language><publisher>Canada: JMIR Publications</publisher><subject>Cell Phone ; Health Personnel ; Humans ; India - epidemiology ; Medication Adherence - psychology ; Medication Adherence - statistics & numerical data ; Original Paper ; Qualitative Research ; Tuberculosis - drug therapy ; Tuberculosis - epidemiology</subject><ispartof>JMIR mHealth and uHealth, 2020-07, Vol.8 (7), p.e16634-e16634</ispartof><rights>Beena E Thomas, J Vignesh Kumar, Chidiebere Onongaya, Spurthi N Bhatt, Amith Galivanche, Murugesan Periyasamy, M Chiranjeevi, Amit Subhash Khandewale, Geetha Ramachandran, Daksha Shah, Jessica E Haberer, Kenneth H Mayer, Ramnath Subbaraman. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 31.07.2020.</rights><rights>Beena E Thomas, J Vignesh Kumar, Chidiebere Onongaya, Spurthi N Bhatt, Amith Galivanche, Murugesan Periyasamy, M Chiranjeevi, Amit Subhash Khandewale, Geetha Ramachandran, Daksha Shah, Jessica E Haberer, Kenneth H Mayer, Ramnath Subbaraman. Originally published in JMIR mHealth and uHealth (http://mhealth.jmir.org), 31.07.2020. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c429t-9e7d513ca8531cfe79df31d113d57e138829a4ca593c119ee4cba18a34f33c0e3</citedby><cites>FETCH-LOGICAL-c429t-9e7d513ca8531cfe79df31d113d57e138829a4ca593c119ee4cba18a34f33c0e3</cites><orcidid>0000-0002-5672-9488 ; 0000-0001-5718-1082 ; 0000-0003-0238-598X ; 0000-0003-2713-2524 ; 0000-0003-2033-1440 ; 0000-0002-9594-9299 ; 0000-0001-7460-733X ; 0000-0003-0168-7847 ; 0000-0001-8352-7323 ; 0000-0003-1973-2212 ; 0000-0001-5845-3190 ; 0000-0002-2063-943X ; 0000-0003-2614-227X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428900/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428900/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32735220$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Thomas, Beena E</creatorcontrib><creatorcontrib>Kumar, J Vignesh</creatorcontrib><creatorcontrib>Onongaya, Chidiebere</creatorcontrib><creatorcontrib>Bhatt, Spurthi N</creatorcontrib><creatorcontrib>Galivanche, Amith</creatorcontrib><creatorcontrib>Periyasamy, Murugesan</creatorcontrib><creatorcontrib>Chiranjeevi, M</creatorcontrib><creatorcontrib>Khandewale, Amit Subhash</creatorcontrib><creatorcontrib>Ramachandran, Geetha</creatorcontrib><creatorcontrib>Shah, Daksha</creatorcontrib><creatorcontrib>Haberer, Jessica E</creatorcontrib><creatorcontrib>Mayer, Kenneth H</creatorcontrib><creatorcontrib>Subbaraman, Ramnath</creatorcontrib><title>Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers</title><title>JMIR mHealth and uHealth</title><addtitle>JMIR Mhealth Uhealth</addtitle><description>99DOTS is a cell phone-based strategy for monitoring tuberculosis (TB) medication adherence that has been rolled out to more than 150,000 patients in India's public health sector. A considerable proportion of patients stop using 99DOTS during therapy.
This study aims to understand reasons for variability in the acceptance and use of 99DOTS by TB patients and health care providers (HCPs).
We conducted qualitative interviews with individuals taking TB therapy in the government program in Chennai and Vellore (HIV-coinfected patients) and Mumbai (HIV-uninfected patients) across intensive and continuation treatment phases. We conducted interviews with HCPs who provide TB care, all of whom were involved in implementing 99DOTS. Interviews were transcribed, coded using a deductive approach, and analyzed with Dedoose 8.0.35 software (SocioCultural Research Consultants, LLC). The findings of the study were interpreted using the unified theory of acceptance and use of technology, which highlights 4 constructs associated with technology acceptance: performance expectancy, effort expectancy, social influences, and facilitating conditions.
We conducted 62 interviews with patients with TB, of whom 30 (48%) were HIV coinfected, and 31 interviews with HCPs. Acceptance of 99DOTS by patients was variable. Greater patient acceptance was related to perceptions of improved patient-HCP relationships from increased phone communication, TB pill-taking habit formation due to SMS text messaging reminders, and reduced need to visit health facilities (performance expectancy); improved family involvement in TB care (social influences); and from 99DOTS leading HCPs to engage positively in patients' care through increased outreach (facilitating conditions). Lower patient acceptance was related to perceptions of reduced face-to-face contact with HCPs (performance expectancy); problems with cell phone access, literacy, cellular signal, or technology fatigue (effort expectancy); high TB- and HIV-related stigma within the family (social influences); and poor counseling in 99DOTS by HCPs or perceptions that HCPs were not acting upon adherence data (facilitating conditions). Acceptance of 99DOTS by HCPs was generally high and related to perceptions that the 99DOTS adherence dashboard and patient-related SMS text messaging alerts improve quality of care, the efficiency of care, and the patient-HCP relationship (performance expectancy); that the dashboard is easy to use (effort expectancy); and that 99DOTS leads to better coordination among HCPs (social influences). However, HCPs described suboptimal facilitating conditions, including inadequate training of HCPs in 99DOTS, unequal changes in workload, and shortages of 99DOTS medication envelopes.
In India's government TB program, 99DOTS had high acceptance by HCPs but variable acceptance by patients. Although some factors contributing to suboptimal patient acceptance are modifiable, other factors such as TB- and HIV-related stigma and poor cell phone accessibility, cellular signal, and literacy are more difficult to address. Screening for these barriers may facilitate targeting of 99DOTS to patients more likely to use this technology.</description><subject>Cell Phone</subject><subject>Health Personnel</subject><subject>Humans</subject><subject>India - epidemiology</subject><subject>Medication Adherence - psychology</subject><subject>Medication Adherence - statistics & numerical data</subject><subject>Original Paper</subject><subject>Qualitative Research</subject><subject>Tuberculosis - drug therapy</subject><subject>Tuberculosis - epidemiology</subject><issn>2291-5222</issn><issn>2291-5222</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVkt1uEzEQhVcIRKuQV0C-QeKCwPpns2sukEJaaKVWDWq4tmbt2cTVxk5tb0TejkfDTUrVXtnjOfqOR3OKYkzLz4zK6Rc6nXLxqjhlTNJJxRh7_ex-UoxjvCvLklJWMVm9LU44q3lulafF3_M_2x6ss25FzmzXYUCnMRLrSFojmWmN2wSt7W3aE98RKc9ulrefCJA59j1ZrL3DyXeIaMhtCpBwtSedD-TaO5t8eMDOzPpIJcmT5dBi0EPvo43kGo3VkKx38Sv5NUA2ydUOM2owB7tFrtGlSMAZcoHQpzWZQ0CyCH5nDYb4rnjTQR9x_HiOit8_zpfzi8nVzc_L-exqogWTaSKxNhXlGpqKU91hLU3HqaGUm6pGypuGSRAaKsk1pRJR6BZoA1x0nOsS-ai4PHKNhzu1DXYDYa88WHV48GGlICSre1QCZDsVuha1lqITTTvNJGMMNKhRMJFZ346s7dBu0Og8YYD-BfRlx9m1WvmdqgVrZFlmwMdHQPD3A8akNjbqvBBw6IeoWJ65bqoyr3lUfDhKdfAxBuyebGipHsKjDuHJuvfP__Sk-h8V_g8NIsG4</recordid><startdate>20200731</startdate><enddate>20200731</enddate><creator>Thomas, Beena E</creator><creator>Kumar, J Vignesh</creator><creator>Onongaya, Chidiebere</creator><creator>Bhatt, Spurthi N</creator><creator>Galivanche, Amith</creator><creator>Periyasamy, Murugesan</creator><creator>Chiranjeevi, M</creator><creator>Khandewale, Amit Subhash</creator><creator>Ramachandran, Geetha</creator><creator>Shah, Daksha</creator><creator>Haberer, Jessica E</creator><creator>Mayer, Kenneth H</creator><creator>Subbaraman, Ramnath</creator><general>JMIR Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-5672-9488</orcidid><orcidid>https://orcid.org/0000-0001-5718-1082</orcidid><orcidid>https://orcid.org/0000-0003-0238-598X</orcidid><orcidid>https://orcid.org/0000-0003-2713-2524</orcidid><orcidid>https://orcid.org/0000-0003-2033-1440</orcidid><orcidid>https://orcid.org/0000-0002-9594-9299</orcidid><orcidid>https://orcid.org/0000-0001-7460-733X</orcidid><orcidid>https://orcid.org/0000-0003-0168-7847</orcidid><orcidid>https://orcid.org/0000-0001-8352-7323</orcidid><orcidid>https://orcid.org/0000-0003-1973-2212</orcidid><orcidid>https://orcid.org/0000-0001-5845-3190</orcidid><orcidid>https://orcid.org/0000-0002-2063-943X</orcidid><orcidid>https://orcid.org/0000-0003-2614-227X</orcidid></search><sort><creationdate>20200731</creationdate><title>Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers</title><author>Thomas, Beena E ; Kumar, J Vignesh ; Onongaya, Chidiebere ; Bhatt, Spurthi N ; Galivanche, Amith ; Periyasamy, Murugesan ; Chiranjeevi, M ; Khandewale, Amit Subhash ; Ramachandran, Geetha ; Shah, Daksha ; Haberer, Jessica E ; Mayer, Kenneth H ; Subbaraman, Ramnath</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c429t-9e7d513ca8531cfe79df31d113d57e138829a4ca593c119ee4cba18a34f33c0e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cell Phone</topic><topic>Health Personnel</topic><topic>Humans</topic><topic>India - epidemiology</topic><topic>Medication Adherence - psychology</topic><topic>Medication Adherence - statistics & numerical data</topic><topic>Original Paper</topic><topic>Qualitative Research</topic><topic>Tuberculosis - drug therapy</topic><topic>Tuberculosis - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Thomas, Beena E</creatorcontrib><creatorcontrib>Kumar, J Vignesh</creatorcontrib><creatorcontrib>Onongaya, Chidiebere</creatorcontrib><creatorcontrib>Bhatt, Spurthi N</creatorcontrib><creatorcontrib>Galivanche, Amith</creatorcontrib><creatorcontrib>Periyasamy, Murugesan</creatorcontrib><creatorcontrib>Chiranjeevi, M</creatorcontrib><creatorcontrib>Khandewale, Amit Subhash</creatorcontrib><creatorcontrib>Ramachandran, Geetha</creatorcontrib><creatorcontrib>Shah, Daksha</creatorcontrib><creatorcontrib>Haberer, Jessica E</creatorcontrib><creatorcontrib>Mayer, Kenneth H</creatorcontrib><creatorcontrib>Subbaraman, Ramnath</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>JMIR mHealth and uHealth</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Thomas, Beena E</au><au>Kumar, J Vignesh</au><au>Onongaya, Chidiebere</au><au>Bhatt, Spurthi N</au><au>Galivanche, Amith</au><au>Periyasamy, Murugesan</au><au>Chiranjeevi, M</au><au>Khandewale, Amit Subhash</au><au>Ramachandran, Geetha</au><au>Shah, Daksha</au><au>Haberer, Jessica E</au><au>Mayer, Kenneth H</au><au>Subbaraman, Ramnath</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers</atitle><jtitle>JMIR mHealth and uHealth</jtitle><addtitle>JMIR Mhealth Uhealth</addtitle><date>2020-07-31</date><risdate>2020</risdate><volume>8</volume><issue>7</issue><spage>e16634</spage><epage>e16634</epage><pages>e16634-e16634</pages><issn>2291-5222</issn><eissn>2291-5222</eissn><abstract>99DOTS is a cell phone-based strategy for monitoring tuberculosis (TB) medication adherence that has been rolled out to more than 150,000 patients in India's public health sector. A considerable proportion of patients stop using 99DOTS during therapy.
This study aims to understand reasons for variability in the acceptance and use of 99DOTS by TB patients and health care providers (HCPs).
We conducted qualitative interviews with individuals taking TB therapy in the government program in Chennai and Vellore (HIV-coinfected patients) and Mumbai (HIV-uninfected patients) across intensive and continuation treatment phases. We conducted interviews with HCPs who provide TB care, all of whom were involved in implementing 99DOTS. Interviews were transcribed, coded using a deductive approach, and analyzed with Dedoose 8.0.35 software (SocioCultural Research Consultants, LLC). The findings of the study were interpreted using the unified theory of acceptance and use of technology, which highlights 4 constructs associated with technology acceptance: performance expectancy, effort expectancy, social influences, and facilitating conditions.
We conducted 62 interviews with patients with TB, of whom 30 (48%) were HIV coinfected, and 31 interviews with HCPs. Acceptance of 99DOTS by patients was variable. Greater patient acceptance was related to perceptions of improved patient-HCP relationships from increased phone communication, TB pill-taking habit formation due to SMS text messaging reminders, and reduced need to visit health facilities (performance expectancy); improved family involvement in TB care (social influences); and from 99DOTS leading HCPs to engage positively in patients' care through increased outreach (facilitating conditions). Lower patient acceptance was related to perceptions of reduced face-to-face contact with HCPs (performance expectancy); problems with cell phone access, literacy, cellular signal, or technology fatigue (effort expectancy); high TB- and HIV-related stigma within the family (social influences); and poor counseling in 99DOTS by HCPs or perceptions that HCPs were not acting upon adherence data (facilitating conditions). Acceptance of 99DOTS by HCPs was generally high and related to perceptions that the 99DOTS adherence dashboard and patient-related SMS text messaging alerts improve quality of care, the efficiency of care, and the patient-HCP relationship (performance expectancy); that the dashboard is easy to use (effort expectancy); and that 99DOTS leads to better coordination among HCPs (social influences). However, HCPs described suboptimal facilitating conditions, including inadequate training of HCPs in 99DOTS, unequal changes in workload, and shortages of 99DOTS medication envelopes.
In India's government TB program, 99DOTS had high acceptance by HCPs but variable acceptance by patients. Although some factors contributing to suboptimal patient acceptance are modifiable, other factors such as TB- and HIV-related stigma and poor cell phone accessibility, cellular signal, and literacy are more difficult to address. Screening for these barriers may facilitate targeting of 99DOTS to patients more likely to use this technology.</abstract><cop>Canada</cop><pub>JMIR Publications</pub><pmid>32735220</pmid><doi>10.2196/16634</doi><orcidid>https://orcid.org/0000-0002-5672-9488</orcidid><orcidid>https://orcid.org/0000-0001-5718-1082</orcidid><orcidid>https://orcid.org/0000-0003-0238-598X</orcidid><orcidid>https://orcid.org/0000-0003-2713-2524</orcidid><orcidid>https://orcid.org/0000-0003-2033-1440</orcidid><orcidid>https://orcid.org/0000-0002-9594-9299</orcidid><orcidid>https://orcid.org/0000-0001-7460-733X</orcidid><orcidid>https://orcid.org/0000-0003-0168-7847</orcidid><orcidid>https://orcid.org/0000-0001-8352-7323</orcidid><orcidid>https://orcid.org/0000-0003-1973-2212</orcidid><orcidid>https://orcid.org/0000-0001-5845-3190</orcidid><orcidid>https://orcid.org/0000-0002-2063-943X</orcidid><orcidid>https://orcid.org/0000-0003-2614-227X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2291-5222 |
ispartof | JMIR mHealth and uHealth, 2020-07, Vol.8 (7), p.e16634-e16634 |
issn | 2291-5222 2291-5222 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_4a9b64c747c94f48b6a18ddda8ece424 |
source | PubMed (Medline); Publicly Available Content Database |
subjects | Cell Phone Health Personnel Humans India - epidemiology Medication Adherence - psychology Medication Adherence - statistics & numerical data Original Paper Qualitative Research Tuberculosis - drug therapy Tuberculosis - epidemiology |
title | Explaining Differences in the Acceptability of 99DOTS, a Cell Phone-Based Strategy for Monitoring Adherence to Tuberculosis Medications: Qualitative Study of Patients and Health Care Providers |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T11%3A03%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Explaining%20Differences%20in%20the%20Acceptability%20of%2099DOTS,%20a%20Cell%20Phone-Based%20Strategy%20for%20Monitoring%20Adherence%20to%20Tuberculosis%20Medications:%20Qualitative%20Study%20of%20Patients%20and%20Health%20Care%20Providers&rft.jtitle=JMIR%20mHealth%20and%20uHealth&rft.au=Thomas,%20Beena%20E&rft.date=2020-07-31&rft.volume=8&rft.issue=7&rft.spage=e16634&rft.epage=e16634&rft.pages=e16634-e16634&rft.issn=2291-5222&rft.eissn=2291-5222&rft_id=info:doi/10.2196/16634&rft_dat=%3Cproquest_doaj_%3E2429785027%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c429t-9e7d513ca8531cfe79df31d113d57e138829a4ca593c119ee4cba18a34f33c0e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2429785027&rft_id=info:pmid/32735220&rfr_iscdi=true |